SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Kairos Pharma, LTD. (KAPA)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
1.5 / 10
Letters
1
Latest Activity
Jan. 21, 2026
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Jan. 21, 2026 CORRESP Neutral/Informational Moderate Kairos Pharma, Ltd. has submitted a request to the SEC for the acceleration of the effective date of its registration statement on Form S-3. The company aims for the registration … Read Filing EDGAR
Jan. 15, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Kairos Pharma, Ltd. that it will not review their registration statement filed on January 13, 2026. The letter emphasizes that the responsibility for t… Read Filing EDGAR
Apr. 22, 2025 CORRESP Neutral/Informational Moderate Kairos Pharma, Ltd. has submitted a request for the acceleration of the effective date of its registration statement on Form S-1, seeking to have it become effective on April 24, … Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.